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NEUROCYSTICERCOSIS PRESENTING AS 
SCHIZOPHRENIA: A CASE REPORT 
B.BHATIA, S.MISHRA, A.S.SRIVASTAVA 
Psychiatric manifestations of neurocysticercosis presenting mainly as organic psychosis are well 
documented. A patient with neurocysticercosis who presented with a schizophrenia like functional 
psychiatric illness is hereby reported. 
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INTRODUCTION 
Neurocysticercosis is the most common parasitic 
disease in the world which affects the central nerv-
ous system (Grisolia & Wiederhold, 1982). Al-
though it has been reported globally (Feng et al, 
1979; McCormick et al, 1982; Grisolia & Wieder-
hold, 1982), important foci exist in China, India, 
Pakistan, Indonesia, Philippines and Latin America 
(Muller et al, 1987). Neurocysticercosis produces a 
variable clinical picture (Sotelo et al, 1985). Al-
though seizures, intracranial hypertension, 
hydrocephalus and stroke are the most frequent 
clinical presentations (McCormick et al, 1982; Tan-
don, 1983; Venkataraman, 1989), a few reports of 
psychiatric manifestations have been published 
from time to time. Psychotic episodes occur in about 
4.7% of patients with neurocysticercosis (Sotelo et 
al, 1985), who usually present with an organic 
psychosis; rarely however, is this the presenting 
symptom. Our case merits attention as the presenting 
symptoms were those of a functional psychosis. 
CASE REPORT 
A 25 year old, illiterate married Hindu male, an 
occasional non- vegetarian from a lower socio-
economic class and a hawker by profession 
presented with a three month history of gradual 
change in behavior in the form of irrelevant talk, 
laughing and weeping without reason, fearfulness, 
suspiciousness and sleep disturbance. The patient 
was initially able to take care of his personal upkeep 
and hygiene but after two months of illness these 
functions deteriorated. Occasional forgetfulness 
was also reported. He had one attack of a generalized 
tonic-clonic seizure one week prior to attending the 
psychiatric out patient department. No past or family 
history of mental illness was present. 
On mental status examination, he was well 
oriented to time, place and person, cooperative,com-
municative and responded well to questions asked. 
No evidence of memory impairment was found. 
Delusions of persecution and reference were 
present. No perceptual anomaly was detected. In-
sight was partial; he accepted the illness but at-
tributed the cause to evil spirits. Psychological 
testing on the Bender Gestalt Test and Post Graduate 
Institute (PGI) Memory Scales did not reveal any 
evidence of organicity. A provisional diagnosis of 
schizophrenia (ICD-9) with primary generalized 
tonic-clonic seizure was.made. The patient was 
treated with haloperidol 20 mg/day and advised 
follow up after three weeks. He was referred to the 
Division of Neurology for opinion and management 
of seizure. 
Examination by the neurologists revealed sub-
cutaneous nodules over the trunk, both thighs and 
calves. These nodules were soft, mobile and non-
tender. Examination of cardiovascular system, chest 
and abdomen revealed no abnormality. Detailed 
central nervous system examination was normal. He 
was treated with phenytoin sodium, 300 mg/day in 
divided doses. Investigations were carried out and 
he was asked to return after three weeks. 
After three weeks of follow up, there was no 
improvement in his behavior. However, he did not 
have any seizure during this period. Investigations 
were as follows: Leukocytosis (total leucocyte count 
12,000/mm ) with evidence of eosinophilia 
(eosinophil count 14%) was present in periph 'al 
blood smear examination. Erythrocyte sedimenta 
tion rate was normal. General blood picture, blood 
urea, blood sugar, serum creatinine, electrolytes and 
liver function tests were within normal limits. Serum 
VDRL was non reactive.- Stool examination was 
negative for Taenia solium in three consecutive 
early morning stool samples. Examination of fundus 
oculi did not reveal any sign of raised intracranial 
tension or deposits of cysticerci. Roentgenograms of 
skull, thighs and calves did not show any calcifica-
tion. An electroencephalogram (EEG) showed 
generalized inter-ictal discharge in the form of inter-
mittent high amplitude sharp and slow waves, last-
ing for 1-2 seconds. There were no spikes, phase 
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reversal or voltage asymmetry. Cerebrospinal fluid 
examination revealed lymphocytic pleocytosis, 
raised protein and normal glucose level. No 
eosinophils were seen in the sediments of 
centrifuged CSF. Cranial computerized tomography 
scan showed multiple, high attenuating (less than 5 
mm size) pin head lesions with perifocal oedema in 
fronto-parieto-occipital regions. A few calcified 
lesions were also present. Ventricle size was normal. 
There was no evidence of generalized oedema. 
A provisional diagnosis of neurocysticercosis 
was made; histopathology report of subcutaneous 
nodule confirmed the diagnosis of cysticercosis cel-
lulosae. The patient was admitted in the neurology 
ward and was treated with albendazole, at a dose of 
15 mg/Kg/day in divided doses for one month. The 
dose of haloperidol was also increased from 20 mg 
to 30 mg per day. A cranial CT scan was repeated 
three months after albendazole therapy, which 
showed a decrease in the number of pin head lesions; 
however, calcified lesions persisted as such. There 
was no evident perifocal oedema. Subcutaneous 
nodules started regressing after albendazole therapy 
and completely disappeared in four months. Sig-
nificant improvement in psychiatric symptoms was 
also observed following albendazole therapy. 
Delusions of persecution and delusions of reference 
were not found on mental status examination. In-
sight also improved; instead of attributing the illness 
to evil spirits, the patient accepted having a physical 
illness. Haloperidol was gradually tapered and 
stopped after three months. However, considering 
the presence of persistent calcified lesions in the 
brain, phenytoin sodium was continued. 
DISCUSSION 
Psychiatric manifestations of neurocysticercosis 
have been reported mainly in the form of organic 
psychosis. Stepien and Chorobski (1949) and 
Stepien (1962) observed mental changes in 28% of 
cases and recorded a loss of orientation in space and 
time as well as visual and auditory hallucinations as 
the most frequent symptoms. Apathy or euphoria, 
confusion or agitation, impairment of memory and 
slowing in mental process were seen less frequently. 
Dixon and Lipscomb (1961) observed mental chan-
ges in 8.7% of cases. Sotclo et al (1985) reported 
occurrence of intellectual deterioration, psychotic 
episodes and disturbances of behavior in one out of 
every five patients, especially in those with 
hydrocephalus or in patients with parenchymal 
lesions. From India, Armstrong in 1888 first 
reported acaseof extensivecysticercosisof thebrain 
in a lunatic who died in the Madras asylum. Kala and 
Wig (1977) reported two cases of organic psychosis 
with marked disorientation, excitement and ir-
relevant talk with raised intracranial tension. They 
also reported a case of slowly progressing dementia 
with loss of memory and impairment of judgement. 
Trivedi et al (1983) reported a case of neurocysticer-
cosis in an alcoholic who presented with a history of 
recurrent generalized tonic-clonic seizures followed 
by organic psychosis. 
Our patient presented mainly with a functional 
psychiatric illness. History of a recent seizure and 
the presence of subcutaneous nodules were the only 
pointers to organic illness. Antipsychotic therapy 
was of no help initially but when albendazole 
therapy was added, significant improvement in be-
havior was reported. Although the possibility of 
purely functional psychiatric illness (schizophrenia) 
cannot be ruled out, the definite evidence of 
neurocysticercosis, clinical response to haloperidol 
only after the addition of specific albendazole 
therapy and previously reported psychiatric abnor-
malities in patients with neurocysticercosis do sug-
gest the possibility of a symptomatic psychosis as a 
result of neurocysticercosis. To the best of our 
knowledge, this is the first report where organic 
psychiatric findings are not part of the presenting 
features. 
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